Table 1.

Distribution of CPE Mechanisms of Resistance Among Newly Diagnosed Patients with CPE Per Type and Year at Rambam Health Care Campus, Haifa, Israel.

Year Total Number of CPE Patients KPC
n (%)
NDM
n (%)
OXA-48
n (%)
IMI
n (%)
2014 95 89 (94%) 4 (4%) 2 (2%) 0
2015 109 100 (92%) 4 (4%) 5 (5%) 0
2016 59 51 (84%) 3 (5%) 5 (8%) 0
2017 65 58 (88%) 4 (6%) 3 (5%) 0
2018 88 58 (66%) 19 (22%) 11 (13%) 0
2019 141 71 (50.5%) 41 (29%) 27 (19%) 2 (1.5%)
2020 134 75 (56%) 39 (29%) 17 (12.7%) 3 (2.3%)

CPE, carbapenemase-producing Enterobacterales; IMI, imipenemase; KPC, Klebsiella pneumoniae carbapenemase; NDM, New Delhi metallo-β-lactamase; OXA, oxacillinases.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2022 January; 13(1): e0004. ISSN: 2076-9172
Published online 2022 January 27. doi: 10.5041/RMMJ.10461